EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuroprotective Effect of Magnoflorine Through Inhibition of Caspase‐3‐Mediated Neuronal Apoptosis: In Silico to In Vitro Validation

Randeep Singh iD, Sahil Arora iD, Rimple Kaur iD, Ali Gharib Gharib iD, Vikash Prashar iD, Tania Arora, Arti Sharma iD, Balachandar Vellingiri iD, Jyoti Parkash iD

Journal of Biochemical and Molecular Toxicology · 2026-11 · 40 (11)

DOI: 10.1002/jbt.71171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 07.11.2026. Verfasst von Randeep Singh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, School of Basic Sciences, Central University of Punjab, Bathinda, Punjab, India. Hauptthemen laut MEDLINE: Apoptosis, Neuroprotective Agents, Caspase 3, Neurons. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anusandhan National Research Foundation, Science and Engineering Research Board, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegeneration is a progressive biological phenomenon that is significantly driven by neuronal apoptosis. The current study aimed to investigate the neuroprotective potential of Magnoflorine, a natural alkaloid, by inhibiting Caspase‐3‐mediated neuronal apoptosis induced by Kainic acid. The caspase‐3‐inhibiting property of Magnoflorine was initially predicted using in silico methods such as molecular docking, MMGBSA analysis, and molecular dynamics (MD) simulations, taking Kainic acid as the reference neurotoxic ligand. Molecular docking and MMGBSA analysis showed that Magnoflorine has a higher binding affinity for caspase‐3 than that of Kainic acid, which predicts the potential of Magnoflorine to inhibit caspase‐3 expression. MD simulations further highlighted this potential through the greater stability of the Caspase‐3‐Magnoflorine complex than the Caspase‐3‐Kainic acid complex over 200 ns of simulations. It was finally evaluated through multiple in vitro techniques such as the MTT cell viability assay, LDH cytotoxicity assay, Annexin V‐PI apoptosis assay, and immunocytochemistry performed on the retinoic acid‐differentiated SH‐SY5Y cells. MTT and LDH assays revealed that Magnoflorine significantly improved the viability of differentiated SH‐SY5Y cells by reducing Kainic acid–induced cell death and cytotoxicity. The apoptosis assay also showed that Magnoflorine significantly reduced the Kainic acid‐induced apoptosis in differentiated SH‐SY5Y cells. Inhibition of Caspase‐3 by Magnoflorine became evident during immunocytochemistry through the reversal of the Kainic acid‐induced increase in Caspase‐3 expression in differentiated SH‐SY5Y cells, as observed from immunofluorescence intensity. The present study suggests that Magnoflorine is emerging as a valuable therapeutic agent for neurodegeneration by alleviating neuronal apoptosis, which requires further validation through in vivo studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisNeuroprotective AgentsCaspase 3NeuronsAporphinesHumansMolecular Docking SimulationCell Line, TumorMolecular Dynamics SimulationKainic Acid

Stichwörter der Autor:innen

Caspase‐3Kainic acidMagnoflorinemolecular dockingneuroprotective

Substanzen

Neuroprotective AgentsCaspase 3AporphinesmagnoflorineCASP3 protein, humanKainic Acid

Autor:innen und Institutionen

  • Department of Zoology, School of Basic Sciences, Central University of Punjab, Bathinda, Punjab, India.
  • Department of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, Bathinda, Punjab, India.
  • Department of Computational Sciences, School of Basic Sciences, Central University of Punjab, Bathinda, Punjab, India.
  • Department of Allied Health Sciences, School of Allied and Healthcare Sciences, Lovely Professional University, Phagwara, Punjab, India.

ORCID-Profile: Randeep Singh, Sahil Arora, Rimple Kaur, Ali Gharib Gharib, Vikash Prashar, Arti Sharma, Balachandar Vellingiri, Jyoti Parkash

Förderung

  • Anusandhan National Research Foundation
  • Science and Engineering Research Board
  • Indian Council of Medical Research

Zitieren

APA

Singh, R., Arora, S., Kaur, R., Gharib Gharib, A., Prashar, V., Arora, T., Sharma, A., Vellingiri, B., & Parkash, J. (2026). Neuroprotective Effect of Magnoflorine Through Inhibition of Caspase‐3‐Mediated Neuronal Apoptosis: In Silico to In Vitro Validation. Journal of Biochemical and Molecular Toxicology, 40(11). https://doi.org/10.1002/jbt.71171

Vancouver

Singh R, Arora S, Kaur R, Gharib Gharib A, Prashar V, Arora T, et al. Neuroprotective Effect of Magnoflorine Through Inhibition of Caspase‐3‐Mediated Neuronal Apoptosis: In Silico to In Vitro Validation. Journal of Biochemical and Molecular Toxicology. 2026;40(11). doi:10.1002/jbt.71171

BibTeX
@article{Singh2026,
  author = {Singh, Randeep and Arora, Sahil and Kaur, Rimple and Gharib Gharib, Ali and Prashar, Vikash and Arora, Tania and Sharma, Arti and Vellingiri, Balachandar and Parkash, Jyoti},
  title = {Neuroprotective Effect of Magnoflorine Through Inhibition of Caspase‐3‐Mediated Neuronal Apoptosis: In Silico to In Vitro Validation},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {11},
  doi = {10.1002/jbt.71171}
}
Kostenlos starten →